vs
Side-by-side financial comparison of Fresenius Medical Care AG (FMS) and PAN AMERICAN SILVER CORP (PAAS). Click either name above to swap in a different company.
Fresenius Medical Care AG is the larger business by last-quarter revenue ($5.5B vs $2.8B, roughly 2.0× PAN AMERICAN SILVER CORP).
Fresenius Medical Care AG & Co. KGaA is a German healthcare company which provides kidney dialysis services through a network of 4,171 outpatient dialysis centers, serving 345,425 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives.
Pan American Silver Corporation is a mining company based in Canada with operations in Latin America. The company has mines and other projects in Mexico, Peru, Bolivia, and Argentina.
FMS vs PAAS — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2022
| Metric | | |
|---|---|---|
| Revenue | $5.5B | $2.8B |
| Net Profit | $434.2M | — |
| Gross Margin | 27.4% | 27.0% |
| Operating Margin | 11.7% | — |
| Net Margin | 7.9% | — |
| Revenue YoY | -0.3% | — |
| Net Profit YoY | 240.4% | — |
| EPS (diluted) | — | $-1.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $5.5B | — | ||
| Q4 24 | $5.5B | — | ||
| Q3 22 | — | $2.8B |
| Q4 25 | $434.2M | — | ||
| Q4 24 | $127.6M | — | ||
| Q3 22 | — | — |
| Q4 25 | 27.4% | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 22 | — | 27.0% |
| Q4 25 | 11.7% | — | ||
| Q4 24 | 5.1% | — | ||
| Q3 22 | — | — |
| Q4 25 | 7.9% | — | ||
| Q4 24 | 2.3% | — | ||
| Q3 22 | — | — |
| Q4 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 22 | — | $-1.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7B | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $15.4B | — |
| Total Assets | $33.5B | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 22 | — | — |
| Q4 25 | $15.4B | — | ||
| Q4 24 | $17.0B | — | ||
| Q3 22 | — | — |
| Q4 25 | $33.5B | — | ||
| Q4 24 | $36.3B | — | ||
| Q3 22 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $2.9B | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | 6.67× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $2.9B | — | ||
| Q4 24 | $2.6B | — | ||
| Q3 22 | — | — |
| Q4 25 | 6.67× | — | ||
| Q4 24 | 20.20× | — | ||
| Q3 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
